The 2-5A System: Modulation of Viral and Cellular Processes Through Acceleration of RNA Degradation
Overview
Authors
Affiliations
The 2-5A system is an RNA degradation pathway that can be induced by the interferons (IFNs). Treatment of cells with IFN activates genes encoding several double-stranded RNA (dsRNA)-dependent synthetases. These enzymes generate 5'-triphosphorylated, 2',5'-phosphodiester-linked oligoadenylates (2-5A) from ATP. The effects of 2-5A in cells are transient since 2-5A is unstable in cells due to the activities of phosphodiesterase and phosphatase. 2-5A activates the endoribonuclease 2-5A-dependent RNase L, causing degradation of single-stranded RNA with moderate specificity. The human 2-5A-dependent RNase is an 83.5 kDa polypeptide that has little, if any, RNase activity, unless 2-5A is present. 2-5A binding to RNase L switches the enzyme from its off-state to its on-state. At least three 2',5'-linked oligoadenylates and a single 5'-phosphoryl group are required for maximal activation of the RNase. Even though the constitutive presence of 2-5A-dependent RNase is observed in nearly all mammalian cell types, cellular amounts of 2-5A-dependent mRNA and activity can increase after IFN treatment. One well-established role of the 2-5A system is as a host defense against some types of viruses. Since virus infection of cells results in the production and secretion of IFNs, and since dsRNA is both a frequent product of virus infection and an activator of 2-5A synthesis, the replication of encephalomyocarditis virus, which produces dsRNA during its life cycle, is greatly suppressed in IFN-treated cells as a direct result of RNA decay by the activated 2-5A-dependent RNase. This review covers the organic chemistry, enzymology, and molecular biology of 2-5A and its associated enzymes. Additional possible biological roles of the 2-5A system, such as in cell growth and differentiation, human immunodeficiency virus replication, heat shock, atherosclerotic plaque, pathogenesis of Type I diabetes, and apoptosis, are presented.
Kim Y, Jeong S, Yang J, Tark D, Kim W, Yang H J Anim Sci Technol. 2025; 67(1):69-85.
PMID: 39974787 PMC: 11833206. DOI: 10.5187/jast.2025.e10.
Briassoulis G, Briassoulis P, Ilia S, Miliaraki M, Briassouli E Antioxidants (Basel). 2023; 12(11).
PMID: 38001795 PMC: 10669546. DOI: 10.3390/antiox12111942.
The role of Neanderthal introgression in liver cancer.
Taravella Oill A, Buetow K, Wilson M BMC Med Genomics. 2022; 15(1):255.
PMID: 36503519 PMC: 9743633. DOI: 10.1186/s12920-022-01405-7.
Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.
Kondratova A, Cheon H, Dong B, Holvey-Bates E, Hasipek M, Taran I EMBO J. 2020; 39(11):e101573.
PMID: 32323871 PMC: 7265237. DOI: 10.15252/embj.2019101573.
Imam H, Kim G, Mir S, Khan M, Siddiqui A PLoS Pathog. 2020; 16(2):e1008338.
PMID: 32059034 PMC: 7046284. DOI: 10.1371/journal.ppat.1008338.